Skip to main content

Table 1 Demographic findings of the patients

From: Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases

Characteristics n (%)
Age (average) 60.3y (26–84 y)
Gender (male/female) 26 (70) / 11 (30)
Symptoms 24 (65)
  Abdominal pain 11
  Abdominal pain + weight loss 6
  Jaundice 5
  Acute pancreatitis 2
Asymptomatic 13 (35)
Diagnosis of metastases  
  Control of disease 29 (78)
   Non-Hodgkin lymphoma 6
   Colon cancer (adenocarcinoma) 4
   Renal cancer (clear renal cell cancer) 4
   Breast cancer 3
   Sarcoma [Leyomiossarcome (1), Rhabdomiossarcome (1) and sarcoma (1)] 3
   Gastric cancer (adenocarcinoma) 2
   Skin cancer (melanoma) 2
   Bladder cancer 1
   Esophageal cancer (squamous cell carcinoma) 1
   Gallbladder cancer 1
   Lung cancer (NSCLG) 1
   Mieloma Multiplus (Plasmocytoma) 1
  Before identification of the primary cancer 6 (15)
   Renal cancer (clear renal cell cancer) 1
   Lung [SCLC(1) and squamous cell carcinoma (2)] 3
   Ovarian cancer 1
   Mesothelyoma 1
  Initial Staging 2 (6)
   Gastric cancer (signet ring cells adenocarcinoma) 1
   Liver (hepatocellular carcinoma) 1
  1. NSCLC: non-small cell lung cancer; SCLG: small cell lung cancer.
  2. Control of disease: periodical control of a previously identified extrapancreatic tumour.
  3. Before identification of the primary cancer: Imaging methods revealed a pancreatic mass, and EUS-FNA confirmed it as a metastatic tumour, without detection of the primary cancer.
  4. Initial staging: an extrapancreatic tumour and a pancreatic mass or enlargement were detected at the same time.